HMOX1 and ganglioneuroma: Long-term subcutaneous FePP administration (initiated 24 h before induction of GN and subsequently administered on days 1, 3, and 6 thereafter to achieve sustained HO-1 induction) increased HO-1 expression (assessed by immunolocalization) in infiltrating macrophages and tubular epithelial cells.